Navigation Links
CardioVascular BioTherapeutics, Inc. Announces Update on Timing of Form 10-K Filing
Date:4/21/2008

LAS VEGAS, April 21 /PRNewswire-FirstCall/ -- CardioVascular BioTherapeutics, Inc. (OTC Bulletin Board: CVBT) has announced that the Over the Counter Bulletin Board (OTCBB), on which CVBT's stock is traded, has added a temporary "E" to the end of its ticker symbol. The temporary "E" designates the late filing of the Company's Annual Report (Form 10-K).

Pursuant to OTCBB rules, CVBT's listing will continue through May 15, 2008 provided the Company files it Annual Report before this date. After the OTCBB confirms the filing, the "E" will be removed from the ticker symbol.

On Friday, April 18th, CVBT submitted a Form 8-K stating that it was unable to file its Annual Report on time as additional time was necessary to ensure adequate disclosure of required information.

About CardioVascular BioTherapeutics

CVBT is a biopharmaceutical company developing human FGF-1 for cardiovascular diseases characterized by inadequate blood flow to a tissue or organ. In addition to the Phase II trial it is conducting in patients with severe coronary heart disease, the company has two FDA-authorized clinical trials underway in the areas of impaired wound healing seen in diabetes and in patients suffering from peripheral artery disease of the legs. An additional trial is also being conducted in patients with chronic back pain who may have perfusion defects to their spine.

CardioVascular BioTherapeutics, Inc.

Allison Lipson, (702) 839-7200

alipson@cvbt.com


'/>"/>
SOURCE CardioVascular BioTherapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1

Related biology technology :

1. BRISTOL-MYERS SQUIBB SELECTS ISIS DRUG TARGETING PCSK9 AS DEVELOPMENT CANDIDATE FOR PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASE
2. Significant Reductions in Mortality and Cardiovascular Events Shown Using Blood Pressure-Lowering Treatment in Those Aged 80 and Over
3. HealthAware Introduces Its VascularAware Cardiovascular Disease Module
4. GlaxoSmithKline Responds to JAMA Article on the ICES Thiazolidinediones and Cardiovascular Outcomes in Older Patients with Diabetes
5. VIA Pharmaceuticals Expands Clinical Advisory Board With Leading Experts in Cardiovascular Disease
6. VIA Pharmaceuticals Lead Compound, VIA-2291, Chosen as a Top Ten Most Licensable Cardiovascular Program for Windhover Informations Therapeutic Area Partnerships Conference
7. Amarin Announces Initiation of Cardiovascular Development Strategy
8. NFL Hall of Fame Legend Fred Biletnikoff Joins AFL/Signalife Cardiovascular Protection Team
9. Edwards Lifesciences Grants UC Irvine $5 Million to Establish the Edwards Lifesciences Center for Advanced Cardiovascular Technology
10. Legendary Earvin Magic Johnson Joins AFL/Signalife Cardiovascular Protection Team
11. Northwest Biotherapeutics, Inc. Announces Appointment of Chief Financial Officer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...N, Nov. 25 Biotech firm Replikins ...ata from the 1918 pandemic through the prediction,...ic, today issued its latest biochemical analysis o... of the H1N1 ("Swine Flu") virus has dropped from ...ent outbreak in the spring of 2009 to resting non-...
(Date:11/25/2009)..., ,, BOCA RATON, Fla., Nov. 25 /PRNewswi...l year. Not so for BodyLogicMD. The nation,s larg...ns specializing exclusively in medically supervise... physicians in its network since November 20...s to add more physician-owned centers, including o...
(Date:11/25/2009)...BEIJING, Nov. 25 /PRNewswire-Asia/ -- Sinovac Biot...of vaccines, announced today that it executed,a jo...alian) Vaccine,Technology Co., Ltd. (Sinovac Dalia...mercialize human-use vaccines. Sinovac will contri...d commercializing world-class vaccines; the,other ...
(Date:11/25/2009)... Nov. 25 Ardea Bioscienc...ry D. Quart, Pharm.D., president and chief executi... Annual Health Care Conference. , ,Presentation d...Health Care Conference,Date: Tuesday, Decembe...on: The New York Palace Hotel, New York, NY,Webca...
Breaking Biology Technology:Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Biological H1N1 Vaccines: Too Little, Too Late 5Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 2Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 3Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 4Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2
... TraumaCure Inc. – maker...at™ – today announced that the company...485 certification for its quality system for desig...vices. The company received FDA clearance to sell ... BETHESDA, Md. (Business Wire EON) June 24, 2008...
...Recognizes Entrepreneurial Excellence in Emerging ...iotechnology,company, today announced that Dr. Don...rnst & Young Entrepreneur Of The Year(R) 2008 Awar...les Area. According to Ernst &,Young LLP, the awar...lding,and leading dynamic, growing businesses. Dr....
...AL, June 25 /PRNewswire-FirstCall/ - ProMetic Life...day that it has further confirmed the,efficacy of ...oval and,Diagnostic Technologies Inc. ("PRDT"), in...ncluding mixtures of proteins containing high,conc...n and 3%,immunoglobulin solutions without affectin...
Other Biology Technology: TraumaCure Receives Prestigious ISO 13485 Certification 2Agensys Founder, President, & CEO Dr. Donald Rice Named Ernst & Young Entrepreneur Of The Year(R) 2008 Award Winner for the Greater Los Angeles Area 2Agensys Founder, President, & CEO Dr. Donald Rice Named Ernst & Young Entrepreneur Of The Year(R) 2008 Award Winner for the Greater Los Angeles Area 3ProMetic Further Confirms Performance of Prion Capture Resin at the Recovery of Biological Products Conference 2ProMetic Further Confirms Performance of Prion Capture Resin at the Recovery of Biological Products Conference 3
(Date:11/26/2009)...ght European countries has shown that closing scho... could have a significant role in reducing illness...ess journal BMC Infectious Diseases compared opp...ds/holidays, finding that they were reduced when s...ntwerp University, Belgium, led a team of European...
(Date:11/26/2009)...r 2009 What are the bare essentials of life, the ...ll that can survive on its own? Can we describe th...an entire organism functions as a system? These ar...partnership between the European Molecular Biology... Centre de Regulacio Genmica (CRG) in Barcelona, S...
(Date:11/25/2009)... at the California Institute of Technology (Caltec...like behavior in the fruit fly, Drosophila melano... to the relationship between the neurotransmitter ...der (ADHD), are described in the December issue of...contains only about 20,000 neurons and has long be...
Breaking Biology News(10 mins):School closure could reduce swine flu transmission by 21 percent 2First-ever blueprint of a minimal cell is more complex than expected 2First-ever blueprint of a minimal cell is more complex than expected 3Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 2Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 3Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 4Senator McCaskill Votes to Protect Americas Kids From Tobacco 48700 1Senator McCaskill Votes to Protect Americas Kids From Tobacco 48700 2Senators Bingaman and Udall Vote to Protect Americas Kids From Tobacco 48697 1Senators Bingaman and Udall Vote to Protect Americas Kids From Tobacco 48697 2Senator Brown Leads Fight to Protect Americas Kids from Tobacco 48694 1Senator Brown Leads Fight to Protect Americas Kids from Tobacco 48694 2
...TON, May 26--Researchers from around the world wil...cs, lasers and the application of light waves at t...ternational Quantum Electronics Conference (CLEO/I...Center in Baltimore. , RESEARCH HIGHLIGHTS OF TH...ive Themselves, Flexible Monitors for Future Battl...
...nnels are connexin channels that can dock with eac... membranes. In the June 2009 issue of the Journal...iversity of Medicine and Dentistry, New Jersey) di...w hemichannels are kept closed and lays the framew... open in certain conditions as part of a junctiona...
... N.H. - Scientists from around the world will conv...009, to discuss key findings from the most ambitio... airborne pollutants in the Arctic and determine h...c changes underway in the vast, climate-sensitive ...gn known as POLARCAT was conducted most intensivel...
Other Biology News:Healing wounds with lasers, vehicles that drive themselves, other cutting-edge optics 2Healing wounds with lasers, vehicles that drive themselves, other cutting-edge optics 3Healing wounds with lasers, vehicles that drive themselves, other cutting-edge optics 4Healing wounds with lasers, vehicles that drive themselves, other cutting-edge optics 5Healing wounds with lasers, vehicles that drive themselves, other cutting-edge optics 6Healing wounds with lasers, vehicles that drive themselves, other cutting-edge optics 7Healing wounds with lasers, vehicles that drive themselves, other cutting-edge optics 8Healing wounds with lasers, vehicles that drive themselves, other cutting-edge optics 9Healing wounds with lasers, vehicles that drive themselves, other cutting-edge optics 10Healing wounds with lasers, vehicles that drive themselves, other cutting-edge optics 11Spring agricultural fires have large impact on melting Arctic 2Spring agricultural fires have large impact on melting Arctic 3
50 ml Magnetic Separation Rack from New England Biolabs
Universal Amplification Primer from Invitrogen
Xylene cyanol FF, CI 43535 from Research Organics, Inc.
Sf9 Insect Cells from BD Biosciences Pharmingen
Biology Products: